Kraig Biocraft Laboratories (KBLB) Accumulated Expenses (2010 - 2025)

Kraig Biocraft Laboratories has disclosed Accumulated Expenses across 16 years of filings, most recently posting $3.6 million for Q4 2025.

• Accumulated Expenses for Q4 2025 came in at $3.6 million, up 15.72% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.6 million (up 15.72% YoY), and the FY2025 annual result was $3.6 million, up 15.72% from the prior year.
• Accumulated Expenses came in at $3.6 million for Q4 2025 at Kraig Biocraft Laboratories, up from $3.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $3.6 million in Q4 2025 to a low of $3195.0 in Q2 2023.
• The 5-year median for Accumulated Expenses is $65292.0 (2021), against an average of $1.1 million.
• Peak annual rise in Accumulated Expenses reached 94224.33% in 2023, while the deepest fall reached 95.11% in 2023.
• Kraig Biocraft Laboratories' Accumulated Expenses stood at $31657.0 in 2021, then slumped by 88.22% to $3728.0 in 2022, then surged by 94224.33% to $3.5 million in 2023, then fell by 11.02% to $3.1 million in 2024, then grew by 15.72% to $3.6 million in 2025.
• The last three Accumulated Expenses figures came in at $3.6 million (Q4 2025), $3.5 million (Q3 2025), and $3.4 million (Q2 2025), per Business Quant data.